Increased Serum TNF-α Levels Are Associated With Generalized Anxiety Disorder: A Case-Control Study.
- 1Department of Pharmacy University of Asia Pacific Dhaka Bangladesh.
- 2School of Pharmacy BRAC University Dhaka Bangladesh.
- 3Department of Pharmaceutical Chemistry University of Dhaka Dhaka Bangladesh.
Abstract
Background and aims
Generalized anxiety disorder (GAD) is a mental health disorder that affects many people in all aspects of their lives. It is characterized by persistent and excessive worry that the affected person finds difficult to control. The actual pathophysiology and mechanisms underlying GAD are still elusive. However, cytokines and cell signaling proteins are hypothesized to contribute to the pathogenesis of anxiety. The present study aimed to understand the association of tumor necrosis factor-α (TNF-α) in the pathophysiology of GAD.Methods
This case-control study recruited 43 GAD patients and 26 healthy controls (HCs) matched by age, sex, and other demographic factors. A clinical psychiatrist diagnosed patients and evaluated controls according to DSM-5 criteria. The GAD-7 scale was used to measure the severity of GAD symptoms. Serum TNF-α levels were measured using enzyme-linked immunosorbent assay (ELISA), and appropriate statistical methods were applied to find the associations among the analyzed parameters.Results
The results showed that TNF-α levels in GAD patients were significantly elevated than in HCs. The increased TNF-α levels were positively correlated with the severity of GAD symptoms. Moreover, the ROC curve reveals the AUC, sensitivity, and specificity as 0.888 (95% CI: 0.810-0.966), 84.6%, and 83.3%, respectively, at a cut-off value of 50.86 pg/ml. These results suggest a potential role of TNF-α in the pathophysiology and development of GAD.Conclusion
These findings indicate the role of cytokine dysregulation in GAD pathogenesis. This research advances the understanding of the immune system's association with GAD. However, as this was a cross-sectional case-control study, TNF-α should at present be regarded as a candidate biomarker that needs validation in larger and longer-term studies before it can be used clinically.
Related
- Behavioral, Psychological, and Metabolic Characteristics of Adults with Co-Occurring Generalized Anxiety Disorder and Obesity: A Cross-Sectional Study
- Concerning the harm-benefit ratio of escitalopram for pediatric generalized anxiety disorder. A critical viewpoint on the evidence and approval process
- Integrated Emotional Schema Therapy and the Unified Protocol for Executive Functioning Difficulties and Cognitive Emotion Regulation in Generalized Anxiety Disorder
- Generalized anxiety disorder in forcibly displaced Nagorno-Karabakh population
- Mindfulness-Based Stress Reduction for Generalized Anxiety Disorder: Systematic Review and Meta-Analysis
BibTeX
@article{nur2026increased,
title = {{Increased Serum TNF-α Levels Are Associated With Generalized Anxiety Disorder: A Case-Control Study.}},
author = {Tasnu Ara Nur and Zahra Labiba Ahmed and Faisal Abdullah Emon and Taslima Jamal Urmi and Mohammad Masud Parves and Md Rabiul Islam and Zabun Nahar},
journal = {Health science reports},
year = {2026},
month = oct,
doi = {10.1002/hsr2.73277},
url = {https://europepmc.org/article/MED/42898441},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Increased Serum TNF-α Levels Are Associated With Generalized Anxiety Disorder: A Case-Control Study.
AU - Tasnu Ara Nur
AU - Zahra Labiba Ahmed
AU - Faisal Abdullah Emon
AU - Taslima Jamal Urmi
AU - Mohammad Masud Parves
AU - Md Rabiul Islam
AU - Zabun Nahar
PY - 2026
DA - 2026/10/18
JO - Health science reports
DO - 10.1002/hsr2.73277
UR - https://europepmc.org/article/MED/42898441
AB - Background and aims Generalized anxiety disorder (GAD) is a mental health disorder that affects many people in all aspects of their lives. It is characterized by persistent and excessive worry that the affected person finds difficult to control. The actual pathophysiology and mechanisms underlying GAD are still elusive. However, cytokines and cell signaling proteins are hypothesized to contribute to the pathogenesis of anxiety. The present study aimed to understand the association of tumor necrosis factor-α (TNF-α) in the pathophysiology of GAD.Methods This case-control study recruited 43 GAD patients and 26 healthy controls (HCs) matched by age, sex, and other demographic factors. A clinical psychiatrist diagnosed patients and evaluated controls according to DSM-5 criteria. The GAD-7 scale was used to measure the severity of GAD symptoms. Serum TNF-α levels were measured using enzyme-linked immunosorbent assay (ELISA), and appropriate statistical methods were applied to find the associations among the analyzed parameters.Results The results showed that TNF-α levels in GAD patients were significantly elevated than in HCs. The increased TNF-α levels were positively correlated with the severity of GAD symptoms. Moreover, the ROC curve reveals the AUC, sensitivity, and specificity as 0.888 (95% CI: 0.810-0.966), 84.6%, and 83.3%, respectively, at a cut-off value of 50.86 pg/ml. These results suggest a potential role of TNF-α in the pathophysiology and development of GAD.Conclusion These findings indicate the role of cytokine dysregulation in GAD pathogenesis. This research advances the understanding of the immune system's association with GAD. However, as this was a cross-sectional case-control study, TNF-α should at present be regarded as a candidate biomarker that needs validation in larger and longer-term studies before it can be used clinically.
SN - 2398-8835
ER -